Bruker Acquires PMOD Technologies LLC to Enhance Molecular Imaging Solutions

On July 8, VCBeat (WeChat ID: vcbeat) learned from foreign media that technology giant Bruker announced the acquisition of PMOD Technologies LLC, a provider of molecular imaging research software. PMOD is a company specializing in preclinical molecular imaging research software, with a focus on molecular quantification and pharmacokinetic modeling. PMOD’s software is widely used in neurology, cardiology, and oncology.

PMOD Technologies, founded in 2003 and headquartered in Zurich, maintains an innovative development team in Warsaw, Poland. This acquisition underscores Bruker’s commitment to providing intuitive end-to-end solutions that enhance the efficiency and precision of image analysis in molecular imaging research for nuclear medicine.

The financial terms of the acquisition have not been disclosed, and PMOD continues to be managed by its senior management team. PMOD software remains vendor-neutral and platform-independent, continuing to deliver exceptional service to its customers.

PMOD expands Bruker’s imaging software portfolio for clinical research and further strengthens Bruker’s expertise in nuclear medicine molecular imaging. The portfolio now includes cutting-edge imaging research packages for translational studies in magnetic resonance imaging and nuclear medicine molecular imaging: ParaVision 360 and PMOD.

Dr. Wulf I. Jung, President of Bruker’s Preclinical Imaging division, stated, “With the acquisition of PMOD, Bruker will expand its support for translational research through outstanding imaging tools. PET/MR is a rapidly growing market, and the expertise of the PMOD team will further strengthen our molecular imaging solutions.”

Dr. Cyrill Burger, CEO of PMOD, commented, “Our team is delighted to join Bruker, a globally renowned company known for its innovation and pursuit of excellence. Our combined expertise will accelerate the development of novel molecular imaging applications to meet scientists’ growing demand for innovative research tools.”

PMOD Technologies aims to provide researchers with state-of-the-art software tools for biomedical imaging studies in humans and animals. PMOD software is a comprehensive platform for quantitative imaging and a leading solution for PET molecular imaging. The PMOD software suite includes solutions for image registration, radiomics feature extraction, 3D image visualization, and computational fluid dynamics modeling. PMOD serves a customer base of over 600 sites, with approximately 2,000 active users worldwide. Interactive and responsive collaborations with leading imaging research institutions ensure that PMOD software remains at the forefront of the field.

Bruker helps scientists achieve breakthrough discoveries and develop new applications to improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at the molecular, cellular, and microscopic levels. Through close collaboration with customers, Bruker drives innovation, enhances productivity, and ensures customer success in fields such as molecular life science research, applied and pharmaceutical applications, microtechnology and nanoanalysis, industrial applications, cell biology, preclinical imaging, proteomics research, and clinical microbiology.

(Compiled by: Zhang Jing)